Allan deCamp

16PUBLICATIONS
203CO-AUTHORS
Nanotoxicology, health and safetyMedical biotechnology diagnostics (incl. biosensors)Innate immunityGenetic immunologyProbability theory
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 28, 2026
Prophylactic treatment with broadly neutralizing antibody VRC01 selects for escape mutants after infection in Antibody-Mediated Prevention trials.

|Sep 08, 2026
VRC01 exerted differential pressure on HIV-1 Env from subtypes B and C that continued in the first weeks post-diagnosis in the AMP trials.

|Jul 01, 2026
Vaccination elicits HIV broadly neutralizing antibodies in primates.

|Apr 03, 2026
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials.

Carolyn Williamson, Chivonne Moodley, Craig A Magaret

|May 15, 2025
Vaccination with mRNA-encoded nanoparticles drives early maturation of HIV bnAb precursors in humans.

Jordan R Willis, Madhu Prabhakaran, Michelle Muthui

|Feb 26, 2025
A Pentavalent HIV-1 Subtype C Vaccine Containing Computationally Selected gp120 Strains Improves the Breadth of V1V2 Region Responses.

Xiaoying Shen, Bette Korber, Rachel L Spreng

Pageof 3

Frequent Collaborators

8 joint publications

David Montefiori

7 joint publications

Peter Gilbert

7 joint publications

Craig Magaret

7 joint publications

Michal Juraska